EMBOZENE MICROSPHERES 01-0301-05002-01 15020-S1

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign report with the FDA on 2016-01-21 for EMBOZENE MICROSPHERES 01-0301-05002-01 15020-S1 manufactured by Celonova Biosciences, Gmbh.

Event Text Entries

[36531110] The product will not be returned for evaluation, however investigation of the event is in progress to determine the relationship of the device/product to the event.
Patient Sequence No: 1, Text Type: N, H10


[36531111] On (b)(6) 2015 patient had had a caesarean section for a known placenta percreta (severe form of abnormally adherent placenta). The baby was delivered at caesarean section but the placenta was retained. The intention was to perform a hysterectomy at a later date.
Patient Sequence No: 1, Text Type: D, B5


[40736305] A serious incident review has taken place with external expertise in management of this condition. An inquest is planned for june 2016. In the interim the management of these cases at this hospital has been changed so that uterine artery embolization using embozene microspheres is no longer used for this indication. Event information was requested from the hospital, however, the hospital has not released any information. The hospital indicated that the event was not product related and they continue to use embozene. Based on the information provided by (b)(6), we are assuming that the patient suffered non-target embolization through shunting to the venous system and subsequently to the lung, which supports the finding provided by the (b)(6). However, this has not been confirmed by the hospital. Therefore, at this time, the cause of death seems to be multifactorial triggered by the management of placenta percreta and haemorrhage, although the procedure and the device could not be ruled out. No action will be taken at this time as there is no evidence that the microspheres were the cause of the death. Additionally, this is a first time occurrence of this type of event and no evidence that the product poses a health threat.
Patient Sequence No: 1, Text Type: N, H10


[40736306] On (b)(6) 2015 patient had a caesarean section for a known placenta percreta (severe form of abnormally adherent placenta). The baby was delivered at caesarean section but the placenta was retained. The intention was to perform a hysterectomy at a later date.
Patient Sequence No: 1, Text Type: D, B5


[43884098]
Patient Sequence No: 1, Text Type: N, H10


[43884099] On (b)(6) 2015 patient had had a caesarean section for a known placenta percreta (severe form of abnormally adherent placenta). The baby was delivered at caesarean section but the placenta was retained. The intention was to perform a hysterectomy at a later date.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3007240980-2016-00001
MDR Report Key5383238
Report SourceFOREIGN
Date Received2016-01-21
Date of Report2015-12-22
Date of Event2015-06-04
Date Mfgr Received2015-12-22
Date Added to Maude2016-01-21
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSTEPHANIE FOSSAT-DOMINGUE
Manufacturer Street5840 EL CAMINO REAL STE.111
Manufacturer CityCARLSBAD CA 92008
Manufacturer CountryUS
Manufacturer Postal92008
Manufacturer Phone7606037008
Manufacturer G1CELONOVA BIOSCIENCES, GMBH
Manufacturer StreetERNST-ABBE-STRAUSSE 40 D-8907
Manufacturer CityULM,
Manufacturer CountryGM
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameEMBOZENE MICROSPHERES
Generic NameEMBOLIC DEVICE
Product CodeNAJ
Date Received2016-01-21
Model Number01-0301-05002-01
Catalog Number15020-S1
Lot Number1503173002
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCELONOVA BIOSCIENCES, GMBH
Manufacturer AddressERNST-ABBE-STR. 40 D-89079 ULM, GM


Patients

Patient NumberTreatmentOutcomeDate
101. Death 2016-01-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.